|
advertisement
|
|
|
| Journal Articles Details
|
| Pharmacogenomics Journals |
| Curr Top Med Chem. 4(13):1399-409 |
Pharmacogenomics: the influence of genomic variation on drug response. |
Thomas FJ, McLeod HL, Watters JW.
Washington University School of Medicine, Department of Medicine, Campus Box 8069, St. Louis, MO 63110, USA. jwatters@im.wustl.edu |
Publication Date: Tuesday, September 21, 2004
|
Click here to view MEDLINE citation |
|
More September, 2004 pharmacogenomics journal articles.- Toxicogenomics data: the road to acceptance.
by Freeman K.
Journal: Environ Health Perspect. 112(12):A678-85
- Ethical implications of pharmacogenetics--do slippery slope arguments matter?
by Schubert L.
Journal: Bioethics. 18(4):361-78
- Pharmacogenetics and drug development: the path to safer and more effective drugs.
by Roses AD.
Journal: Nat Rev Genet. 5(9):645-56
- The regulation of pharmacogenomics-based drugs and policy making.
by Issa AM.
Journal: Curr Top Med Chem. 4(13):1455-60
- A resource to acquire and summarize pharmacogenetics knowledge in the literature.
by Rubin DL, Carrillo M, Woon M, Conroy J, Klein TE, Altman RB.
Journal: Medinfo. 2004:793-7
- Encyclopedia of DNA.
by Dahl R.
Journal: Environ Health Perspect. 112(12):A670
- Toxicogenomics in risk assessment: communicating the challenges.
by Pettit SD.
Journal: Environ Health Perspect. 112(12):A662
- The potential clinical and economic outcomes of pharmacogenetics-oriented management of warfarin therapy - a decision analysis.
by You JH, Chan FW, Wong RS, Cheng G.
Journal: Thromb Haemost. 92(3):590-7
- Pharmacogenetic testing, informed consent and the problem of secondary information.
by Netzer C, Biller-Andorno N.
Journal: Bioethics. 18(4):344-60
- Pharmacogenetics: ethical issues.
by Sutrop M.
Journal: Bioethics. 18(4):iii-viii
- SNP discovery and typing technologies for pharmacogenomics.
by Twyman RM.
Journal: Curr Top Med Chem. 4(13):1423-31
- Genotyping as a tool to predict adverse drug reactions.
by Güzey C, Spigset O.
Journal: Curr Top Med Chem. 4(13):1411-21
- Susceptibility to cancer: why did this happen to my child?
by Davies SM.
Journal: Pediatr Blood Cancer. 43(5):536-8
- PedSplit: pedigree management for stratified analysis.
by Lanktree MB, VanderBeek L, Macciardi FM, Kennedy JL.
Journal: Bioinformatics. 04 2004;20(14):2315-6
- [Pharmacogenetic or the promise of a personalized medicine: variability in drug metabolism and transport]
by Allorge D, Loriot MA.
Journal: Ann Biol Clin (Paris). 2004 Sep-Oct;62(5):499-511
- ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan disposition.
by de Jong FA, Marsh S, Mathijssen RH, King C, Verweij J, Sparreboom A, McLeod HL.
Journal: Clin Cancer Res. 10(17):5889-94
- Gene expression profiling in spleens of deoxynivalenol-exposed mice: immediate early genes as primary targets.
by Kinser S, Jia Q, Li M, Laughter A, Cornwell P, Corton JC, Pestka J.
Journal: J Toxicol Environ Health A. 67(18):1423-41
- The use of DNA microarrays to investigate the pharmacogenomics of drug response in living systems.
by Villeneuve DJ, Parissenti AM.
Journal: Curr Top Med Chem. 4(13):1329-45
- Desperately seeking biostatisticians.
by Gimalac A.
Journal: Nat Rev Drug Discov. 3(9):811
More pharmacogenomics journal articles ... |
Journal Articles Categories:
Health Informatics Journal Articles |
Telemedicine Journal Articles |
Hospital Information Systems Journal Articles |
Data Protection and Privacy Journals Articles |
Mobile and Wireless Computing Journal Articles |
Medical Decision Making |
Bioinformatics Journal Articles |
Genomics Journal Articles |
Proteomics Journal Articles |
Pharmacogenomics Journal Articles
|